51.70
Precedente Chiudi:
$47.82
Aprire:
$49.99
Volume 24 ore:
6.98M
Relative Volume:
1.17
Capitalizzazione di mercato:
$9.27B
Reddito:
$1.36B
Utile/perdita netta:
$-302.91M
Rapporto P/E:
-30.09
EPS:
-1.7182
Flusso di cassa netto:
$-219.93M
1 W Prestazione:
+6.33%
1M Prestazione:
+17.61%
6M Prestazione:
-24.76%
1 anno Prestazione:
-27.52%
Tempus Ai Inc Stock (TEM) Company Profile
Nome
Tempus Ai Inc
Settore
Industria
Telefono
800-976-5448
Indirizzo
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, HNGE
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
TEM
Tempus Ai Inc
|
51.62 | 8.59B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
VEEV
Veeva Systems Inc
|
162.30 | 25.92B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
63.78 | 12.41B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
HQY
Healthequity Inc
|
86.39 | 7.39B | 1.34B | 230.70M | 440.96M | 2.6695 |
|
HNGE
Hinge Health Inc
|
67.25 | 5.06B | 646.34M | -512.40M | 202.76M | -6.6871 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-13 | Iniziato | Jefferies | Underperform |
| 2026-04-13 | Aggiornamento | TD Cowen | Hold → Buy |
| 2026-02-19 | Iniziato | Mizuho | Outperform |
| 2026-02-17 | Iniziato | Robert W. Baird | Outperform |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-10-21 | Downgrade | TD Cowen | Buy → Hold |
| 2025-10-20 | Iniziato | Canaccord Genuity | Buy |
| 2025-09-02 | Iniziato | H.C. Wainwright | Buy |
| 2025-04-21 | Iniziato | BTIG Research | Buy |
| 2025-02-25 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-02-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | Ripresa | TD Cowen | Buy |
| 2024-12-13 | Iniziato | Wolfe Research | Outperform |
| 2024-12-09 | Iniziato | Guggenheim | Buy |
| 2024-11-11 | Downgrade | Stifel | Buy → Hold |
| 2024-10-02 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-08-12 | Iniziato | Piper Sandler | Neutral |
| 2024-07-09 | Iniziato | BofA Securities | Buy |
| 2024-07-09 | Iniziato | JP Morgan | Overweight |
| 2024-07-09 | Iniziato | Longbow | Buy |
| 2024-07-09 | Iniziato | Loop Capital | Buy |
| 2024-07-09 | Iniziato | Morgan Stanley | Overweight |
| 2024-07-09 | Iniziato | Needham | Buy |
| 2024-07-09 | Iniziato | Stifel | Buy |
| 2024-07-09 | Iniziato | TD Cowen | Buy |
| 2024-07-09 | Iniziato | William Blair | Outperform |
Mostra tutto
Tempus Ai Inc Borsa (TEM) Ultime notizie
Entropy Technologies LP Purchases New Holdings in Tempus AI, Inc. $TEM - MarketBeat
Tempus AI (TEM) Stock After 23% Year-To-Date Decline Is Opportunity Emerging - Yahoo Finance
Tangible book value per share of Tempus AI, Inc. Shs A Cert Deposito Arg Repr 0.08333333 Sh A – BCBA:TEM.CI - TradingView
Revenue per share of Tempus AI, Inc. Shs A Cert Deposito Arg Repr 0.08333333 Sh A – BCBA:TEM.CI - TradingView
Kelli Teno-Manalli Joins Tempus AI as Vice President, Head of Communications - hrtoday.in
Tempus AI Stock (TEM) Opinions on Earnings Guidance and Acquisition Speculation - Quiver Quantitative
Tempus AI: AI Precision Medicine With A Moat (NASDAQ:TEM) - Seeking Alpha
Tempus AI (TEM) Achieves Major Milestone with ECG Software Validation - GuruFocus
Tempus AI study validates heart rhythm prediction software - Investing.com
Tempus AI study validates heart rhythm prediction software By Investing.com - Investing.com Australia
Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm - Business Wire
Franklin Resources Inc. Has $109.94 Million Holdings in Tempus AI, Inc. $TEM - MarketBeat
TEM News | TEMPUS AI INC-CL A (NASDAQ:TEM) - ChartMill
Tempus AI (TEM) Is One Of The Best Healthcare Mid-Cap AI Stock According To Analysts - Yahoo Finance
Amova Asset Management Americas Inc. Has $206.96 Million Stock Position in Tempus AI, Inc. $TEM - MarketBeat
Tempus AI: The Compression Has Outrun The BusinessUpgrading To Buy (NASDAQ:TEM) - Seeking Alpha
Tempus AI: A Unique AI Business Model With Asymmetric Upside (NASDAQ:TEM) - Seeking Alpha
RNA add-on to DNA tests helps turn uncertain genes into answers - Stock Titan
Alethea Capital Management LLC Makes New Investment in Tempus AI, Inc. $TEM - MarketBeat
Tempus AI, Inc. (NASDAQ:TEM) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Tempus AI, Inc. (NASDAQ:TEM) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
TEM: Tempus leverages integrated data and AI to drive diagnostics growth and pharma partnerships - TradingView
Great News: This Explosive Healthcare Stock Could Be a Powerful Artificial Intelligence Winner - The Motley Fool
AI that predicts clinical outcomes? Tempus AI in focus after ASCO data reveal - MSN
Norges Bank Purchases New Position in Tempus AI, Inc. $TEM - MarketBeat
Contrarius Group Holdings Ltd Makes New Investment in Tempus AI, Inc. $TEM - MarketBeat
Tempus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference - BioSpace
Tempus AI, Inc. Class A Trade Ideas — XETR:F3M - TradingView
Tempus AI to present at Goldman Sachs healthcare conference - scanx.trade
A Quick Look at Today's Ratings for Tempus AI(TEM.US), With a Forecast Between $60 to $80 - Moomoo
Geode Capital Management LLC Boosts Holdings in Tempus AI, Inc. $TEM - MarketBeat
TEM Stock Quote Price and Forecast - CNN
Tempus AI (NASDAQ:TEM) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Quanterix partners with Tempus AI on Alzheimer’s blood test - Investing.com
Tempus AI, Inc. Class A Common Stock (TEM) Live Share Price, Invest From India - INDmoney
Assessing Tempus AI (TEM) Valuation After Recent Share Price Rebound And Underpriced Growth Narrative - Yahoo Finance
TD Cowen raises Tempus AI stock price target on genomics strength - Investing.com
ARK's Stock Pick: $LLY & $TEM Hold Strong as AI Growth Stocks Plunge — Defensive Biotech Shines - Moomoo
$Tempus AI (TEM.US)$ Luckily, I exited yesterday[Lol] - Moomoo
TEM Technical Analysis & Stock Price Forecast - Intellectia AI
Tempus (TEM) Gets Double-Digit Boost from New Partnerships - Insider Monkey
Tempus AI (NASDAQ:TEM) Trading Up 9.3%Time to Buy? - MarketBeat
Tempus AI Stock Pops As FDA Win Fuels Growth Story - StocksToTrade
Why Tempus AI Stock Is Surging On Thursday?Tempus AI (NASDAQ:TEM) - Benzinga
Tempus AI falls on wider loss despite revenue beat By Investing.com - Investing.com Australia
Tempus AI (TEM) Jumps As FDA Win Fuels Bullish Momentum - timothysykes.com
Why Is Tempus (TEM) Down 11.2% Since Last Earnings Report? - Yahoo Finance
$Tempus AI (TEM.US)$ thanks for the ride [Drool] - Moomoo
Tempus Launches Open-Source Digital Pathology Consortium, Names Yale New Haven Health and Leading Cancer Center as Founding Members - BioSpace
Tempus AI launches digital pathology open-source consortium - Investing.com UK
Tempus AI (TEM) director Epstein sells 250 shares in pre-planned trade - Stock Titan
Tempus Ai Inc Azioni (TEM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Tempus Ai Inc Azioni (TEM) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| LEFKOFSKY ERIC P | CEO and Chairman |
May 27 '26 |
Sale |
46.70 |
166,250 |
7,763,312 |
8,808,533 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):